We previously developed radioimmunoassays (RIAs) for digitoxin and digoxin using antisera raised against digitoxin 3’-hemisuccinate-bovine serum albumin and digoxin 3’-hemisuccinate-bovine serum albumin conjugates, respectively. Very recently, we converted the RIA for digoxin to an enzyme immunoassay (EIA) system. Here, we aimed to convert the RIA for digitoxin to an EIA suitable for measuring serum digitoxin level in patients, using digitoxin 3’-hemisuccinate-β-D-galactosidase as an enzyme-labeled antigen. The developed EIA showed a quantification range of 1 to 70 ng/mL and exhibited high specificity for digitoxin, with low cross-reactivity to digitoxin metabolites. Compared with a commercial anti-digitoxin antiserum clinically used to monitor serum digitoxin level in patients, our antiserum showed much higher specificity for intact digitoxin. Intra- and inter-assay variations were less than 10.0% and 8.5%, respectively. Recovery was within the range of 93.7% - 107.5%. Mean digitoxin concentrations measured in serum samples (n = 26) from digitoxin-treated patients by EIA using our new antiserum and the commercial anti-digitoxin antiserum were 11.0 and 13.8 ng/mL, respectively. The present EIA, which is superior to RIA in terms of convenience and disposal of waste materials, is expected to be practically useful for clinical monitoring of intact digitoxin in serum.
References
[1]
Butler Jr., V.P. and Chen, J.P. (1967) Digoxin-Specific Antibodies. Proceedings of the National Academy of Science, USA, 57, 71-78. http://dx.doi.org/10.1073/pnas.57.1.71
[2]
Smith, T.W., Butler, Jr., V.P. and Haber, E. (1970) Characterization of Antibodies of High Affinity and Specificity for the Digitalis Glycoside Digoxin. Biochemistry, 9, 331-337. http://dx.doi.org/10.1021/bi00804a020
[3]
Valdes Jr., R., Brown, B.A. and Graves, S.W. (1984) Variable Cross-Reactivity of Digoxin Metabolites in Digoxin Immunoassays. American Journal of Clinical Pathology, 82, 210-213. http://dx.doi.org/10.1093/ajcp/82.2.210
[4]
Soldin, S.J. (1986) Digoxin—Issues and Controversies. Clinical Chemistry, 32, 5-12.
[5]
Miller, J.J., Straub Jr., R.W. and Valdes Jr., R. (1994) Digoxin Immunoassay with Cross-Reactivity of Digoxin Metabolites Proportional to Their Biological Activity. Clinical Chemistry, 40, 1898-1903.
[6]
Graves, P.E., Perrier, D. and Marcus, F.I. (1983) Quantitation of Digitoxin and the Bis- and Monodigitoxosides of Digitoxigenin in Serum. Journal of Chromatography, 278, 397-405. http://dx.doi.org/10.1016/S0378-4347(00)84799-4
[7]
Santos, S.R., Kirch, W. and Ohnhaus, E.E. (1987) Simultaneous Analysis of Digitoxin and Its Clinically Relevant Metabolites Using High-Performance Liquid Chromatography and Radioimmunoassay. Journal of Chromatography, 419, 155-164. http://dx.doi.org/10.1016/0378-4347(87)80274-8
[8]
Bodem, G. and Unruh, E.V. (1979) Enhanced Transformation of Digitoxin to Dihydrodigitoxin in Humans with Renal Failure. Journal of Clinical Pharmacology, 19, 195-199. http://dx.doi.org/10.1002/j.1552-4604.1979.tb01651.x
[9]
Shimada, K., Mizusawa, S., Ohkubo, T. and Nambara, T. (1984) Preparation of Specific Antisera to Digoxin Using Hapten-[C-17]- and [C-12]-Bovine Serum Albumin Conjugates. Chemical and Pharmaceutical Bulletin, 32, 2301- 2306. http://dx.doi.org/10.1248/cpb.32.2301
[10]
Thong, B., Soldin, S.J. and Lingwood, C.A. (1985) Lack of Specificity of Current Anti-Digoxin Antibodies, and Preparation of a New, Specific Polyclonal Antibody That Recognizes the Carbohydrate Moiety of Digoxin. Clinical Chemistry, 31, 1625-1631.
[11]
Fujii, Y., Ikeda, Y., Fujii, M. and Yamazaki M. (1994) Preparation and Antigenic Properties of Digitoxin-Bovine Serum Albumin Conjugates Linked at the Digitoxose C-3’ and C-3’’ Positions. Biological and Pharmaceutical Bulletin, 17, 467-471. http://dx.doi.org/10.1248/bpb.17.467
[12]
Ikeda, Y., Fujii, M., Yamazaki, M. and Fujii, Y. (2001) Measurement of Serum Digitoxin in Patients by Radioimmunoassay Using Specific Serum. Clinica Chimica Acta, 314, 245-247.
http://dx.doi.org/10.1016/S0009-8981(01)00635-0
[13]
Ikeda, Y. and Fujii, Y. (2000) Preparation of Specific Antisera to Digoxin by Using Digoxin C-3’ and C-3’’ Hemisuccinate-Bovine Serum Albumin Conjugates. Biological and Pharmaceutical Bulletin, 23, 906-910.
http://dx.doi.org/10.1248/bpb.23.906
[14]
Fujii, Y., Ikeda, Y. and Yamazaki, M. (1994) Highly Specific Anti-Digoxin Antiserum from Immunization with Digoxin 3’-Hemisuccinate-Bovine Serum Albumin Conjugate. Clinical Chemistry, 40, 172-173.
[15]
Higashi, Y., Ikeda, Y., Yamamoto, R., Yamashiro, M. and Fujii Y. (2005) Pharmacokinetic Interaction with Digoxin and Glucocorticoids in Rats Detected by Radio-Immunoassay Using a Novel Specific Antiserum. Life Science, 77, 1055-1067. http://dx.doi.org/10.1016/j.lfs.2005.03.003
[16]
Ikeda, Y., Araki, T., Takimoto, H. and Fujii, Y. (2002) Development of Radioimmunoassay for Measurement of Serum Digoxin in Digitalized Patients Using Novel Anti-Digoxin Antiserum. Biological and Pharmaceutical Bulletin, 25, 422-425. http://dx.doi.org/10.1248/bpb.25.422
[17]
Ikeda, Y. and Fujii Y. (2005) Properties of Novel Anti-Digoxin Antisera in Radioimmunoassay Using Homologous and Site Heterologous Tritium-Labeled Antigens Involving a [3H]-Leucine Moiety. Biological and Pharmaceutical Bulletin, 28, 340-343. http://dx.doi.org/10.1248/bpb.28.340
[18]
Guan, F., Ishii, A., Seno, H., Watanabe-Suzuki, K., Kumazawa, T. and Suzuki, O. (1999) Identification and Quantification of Cardiac Glycosides in Blood and Urine Samples by HPLC/MS/MS. Analytical Chemistry, 71, 4034-4043.
http://dx.doi.org/10.1021/ac990268c
[19]
Yao, M., Zhang, H., Chong, S., Zhu, M. and Morrison, R.A. (2003) A Rapid and Sensitive LC/MS/MS Assay for Quantitative Determination of Digitoxin in Rat Plasma. Journal of Pharmaceutical and Biomedical Analysis, 32, 1189-1197. http://dx.doi.org/10.1016/S0731-7085(03)00050-5
[20]
Kaiser, P., Kramer, U., Meissner, D., Kress, M., Wood, W.G. and Reinauer, H. (2003) Determination of the Cardiac Glycosides Digoxin and Digitoxin by Liquid Chromatography Combined with Isotope-Dilution Mass Spectrometry (LC-IDMS)—A Candidate Reference Measurement Procedure. Clinical Laboratory, 49, 329-343.
[21]
Mitamura, K., Horikawa, A., Nagahara, A., Shimada, K. and Fujii, Y. (2005) Determination of Digitoxin in Human Serum Using Stable Isotope Diluted Liquid Chromatography/Electrospray Ionization-Tandem Mass Spectrometry. Journal of Liquid Chromatography & Related Technologies, 28, 2839-2848.
http://dx.doi.org/10.1080/10826070500269869
[22]
Higashi, Y., Ikeda, Y., Yamamoto, N. and Fujii, Y. (2015) Establishment of a Highly Specific Enzyme Immunoassay for Digoxin in Human Serum. Jacobs Journal of Nanomedicine and Nanotechnology, 1, 1-6.
[23]
Haack, E., Kaiser, F. and Spingler, H. (1957) Digoxigenin Mono- and Bis-Digitoxoside, Two New Glycoside of Digitalis Lanata. Naturwissenschaften, 44, 633-634. http://dx.doi.org/10.1007/BF01177965
[24]
Higashi, Y., Watanabe, N., Sasaki, T. and Fujii, Y. (2002) Establishment of Enzyme Immunoassay for Measuring β- Methyldigoxin Levels in Human Serum by Specific Antiserum. Biological and Pharmaceutical Bulletin, 25, 1251- 1257. http://dx.doi.org/10.1248/bpb.25.1251
